Connecticut 2019 Regular Session

Connecticut House Bill HB07287 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	LCO \\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07287-R01-
4		-	HB.docx
5		-	1 of 3
	3	+	LCO No. 5123 1 of 3
6	4
7		-	General Assembly ~~Substitute~~ Bill No. 7287
	5	+	General Assembly Raised Bill No. 7287
8	6		January Session, 2019
	7	+	LCO No. 5123
9	8
	9	+
	10	+	Referred to Committee on GENERAL LAW
	11	+
	12	+
	13	+	Introduced by:
	14	+	(GL)
10	15
11	16
12	17
13	18
14	19		AN ACT CONCERNING RE VISIONS TO THE MEDICAL MARIJUANA
15	20		PROGRAM.
16	21		Be it enacted by the Senate and House of Representatives in General
17	22		Assembly convened:
18	23
19	24		Section 1. Subdivision (3) of section 21a-408 of the general statutes is 1
20	25		repealed and the following is substituted in lieu thereof (Effective from 2
21	26		passage): 3
22	27		(3) "Debilitating medical condition" means (A) cancer, glaucoma, 4
23	28		positive status for human immunodeficiency virus or acquired 5
24	29		immune deficiency syndrome, Parkinson's disease, multiple sclerosis, 6
25	30		damage to the nervous tissue of the spinal cord with objective 7
26	31		neurological indication of intractable spasticity, epilepsy or 8
27	32		uncontrolled intractable seizure disorder, cachexia, wasting syndrome, 9
28	33		Crohn's disease, posttraumatic stress disorder, irreversible spinal cord 10
29	34		injury with objective neurological indication of intractable spasticity, 11
30	35		cerebral palsy, cystic fibrosis, [or] terminal illness requiring end-of-life 12
31	36		care, or opioid use disorder, except, if the qualifying patient is under 13
32	37		eighteen years of age, "debilitating medical condition" means terminal 14
33		-	illness requiring end-of-life care, irreversible spinal cord injury with 15
	38	+	illness requiring end-of-life care, irreversible spinal cord injury with 15 Raised Bill No. 7287
	39	+
	40	+
	41	+
	42	+	LCO No. 5123 2 of 3
	43	+
34	44		objective neurological indication of intractable spasticity, cerebral 16
35	45		palsy, cystic fibrosis, severe epilepsy or uncontrolled intractable 17
36	46		seizure disorder, or (B) any medical condition, medical treatment or 18
37		-	disease approved for qualifying patients by the Department of 19 Substitute Bill No. 7287
38		-
39		-
40		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07287-
41		-	R01-HB.docx }
42		-	2 of 3
43		-
	47	+	disease approved for qualifying patients by the Department of 19
44	48		Consumer Protection pursuant to regulations adopted under section 20
45	49		21a-408m; 21
46	50		Sec. 2. Subsection (a) of section 21a-408d of the general statutes is 22
47	51		repealed and the following is substituted in lieu thereof (Effective from 23
48	52		passage): 24
49	53		(a) Each qualifying patient who is issued a written certification for 25
50	54		the palliative use of marijuana under subdivision (1) of subsection (a) 26
51	55		of section 21a-408a, and the primary caregiver of such qualifying 27
52	56		patient, shall register with the Department of Consumer Protection. 28
53	57		Such registration shall be effective from the date the Department of 29
54	58		Consumer Protection issues a certificate of registration until the 30
55	59		expiration of the written certification issued by the physician or 31
56	60		advanced practice registered nurse. The qualifying patient and the 32
57	61		primary caregiver shall provide sufficient identifying information, as 33
58	62		determined by the department, to establish the personal identity of the 34
59	63		qualifying patient and the primary caregiver. If the qualifying patient 35
60	64		is under eighteen years of age and not an emancipated minor, the 36
61	65		custodial parent, guardian or other person having legal custody of the 37
62	66		qualifying patient shall also provide a letter from both the qualifying 38
63	67		patient's primary care provider and a physician who is board certified 39
64	68		in an area of medicine involved in the treatment of the debilitating 40
65	69		condition for which the qualifying patient was certified that confirms 41
66	70		that the palliative use of marijuana is in the best interest of the 42
67	71		qualifying patient. A physician may issue a written certification for the 43
68	72		palliative use of marijuana by a qualifying patient who is under 44
69	73		eighteen years of age, provided such written certification shall not be 45
70	74		for marijuana in a dosage form that requires that the marijuana be 46
71	75		smoked, inhaled or vaporized. The qualifying patient or the primary 47
72	76		caregiver shall report any change in the identifying information to the 48
73		-	department not later than five business days after such change. The 49
	77	+	department not later than five business days after such change. The 49 Raised Bill No. 7287
	78	+
	79	+
	80	+
	81	+	LCO No. 5123 3 of 3
	82	+
74	83		department shall issue a registration certificate to the qualifying 50
75	84		patient and to the primary caregiver [and may charge a reasonable fee, 51
76		-	not to exceed twenty-five dollars, for each registration certificate 52 Substitute Bill No. 7287
77		-
78		-
79		-	LCO {\\PRDFS1\HCOUSERS\BARRYJN\WS\2019HB-07287-
80		-	R01-HB.docx }
81		-	3 of 3
82		-
	85	+	not to exceed twenty-five dollars, for each registration certificate 52
83	86		issued under this subsection] at no charge. [Any registration fees 53
84	87		collected by the department under this subsection shall be paid to the 54
85	88		State Treasurer and credited to the General Fund.] 55
86		-	Sec. 3. (NEW) (Effective from passage) The Commissioner of 56
87		-	Consumer Protection shall cease charging the nonrefundable fee for 57
88		-	administrative costs for each qualifying patient and the nonrefundable 58
89		-	application fee for each qualifying patient and caregiver under chapter 59
90		-	420f of the general statutes. The commissioner shall also cease charging 60
91		-	the renewal fee for each qualifying patient under chapter 420f of the 61
92		-	general statutes. The commissioner shall amend existing regulations to 62
93		-	eliminate such fees in accordance with the provisions of this section. 63
94	89		This act shall take effect as follows and shall amend the following
95	90		sections:
96	91
97	92		Section 1 from passage 21a-408(3)
98	93		Sec. 2 from passage 21a-408d(a)
99		-	Sec. 3 from passage New section
100	94
101		-	GL Joint Favorable Subst.
	95	+	Statement of Purpose:
	96	+	To amend palliative use of marijuana statutes by adding opioid use
	97	+	disorder as a debilitating medical condition and eliminating the
	98	+	qualifying patient and primary caregiver registration certificate fee.
	99	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline,
	100	+	except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is
	101	+	not underlined.]
102	102